Its development is driven by multifactorial processes, including genetic mutations (e.g., in *BRCA1/BRCA2* and PIK3CA genes) and hormonal influences such as prolonged estrogen exposure, which promote tumor initiation and progression[1]. The gene discussed is PIK3CA; the disease is neoplasm.